A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma
Clinical trial NCT02099656 · COMPLETED
Trial details
- NCT number
- NCT02099656
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-06
- Primary completion
- 2016-10-13
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.